Literature DB >> 16767392

Pegylated interferon-associated retinopathy in chronic hepatitis C patients.

Hiroko Ogata, Hiromasa Suzuki, Kimiya Shimizu, Hitoshi Ishikawa, Namiki Izumi, Masayuki Kurosaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16767392     DOI： 10.1007/s10384-005-0301-1

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN： 0021-5155            Impact factor:   2.211


× No keyword cloud information.
  3 in total

1.  Peginterferon alfa-2a in patients with chronic hepatitis C.

Authors:  S Zeuzem; S V Feinman; J Rasenack; E J Heathcote; M Y Lai; E Gane; J O'Grady; J Reichen; M Diago; A Lin; J Hoffman; M J Brunda
Journal:  N Engl J Med       Date:  2000-12-07       Impact factor: 91.245

Review 2.  [Effectiveness of long-acting interferon (peginterferon)].

Authors:  Yuji Kondo; Ryosuke Tateishi; Haruhiko Yoshida; Masao Omata
Journal:  Nihon Rinsho       Date:  2004-07

3.  [Interferon-induced retinal changes].

Authors:  T Chuman; N Nao-i; A Sawada; T Kawano; M Shigehira
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1994-06
  3 in total
  2 in total

Review 1.  Ophthalmologic complications of antiviral therapy in hepatitis C treatment.

Authors:  Roderick O'Day; Mark C Gillies; Golo Ahlenstiel
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

2.  Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin.

Authors:  Ei Tae Kim; Lee Hoo Kim; Jung Il Lee; Hee Seung Chin
Journal:  Jpn J Ophthalmol       Date:  2009-12-18       Impact factor: 2.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.